What is the share price of Biogen Pharmachem Industries Ltd (BIOGEN) today?
The share price of BIOGEN as on 18th July 2025 is ₹0.93. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Biogen Pharmachem Industries Ltd (BIOGEN) share?
The past returns of Biogen Pharmachem Industries Ltd (BIOGEN) share are- Past 1 week: 1.08%
- Past 1 month: -3.09%
- Past 3 months: -2.11%
- Past 6 months: -18.42%
- Past 1 year: -38.41%
- Past 3 years: N/A%
- Past 5 years: 200.00%
What are the peers or stocks similar to Biogen Pharmachem Industries Ltd (BIOGEN)?
The peers or stocks similar to Biogen Pharmachem Industries Ltd (BIOGEN) include:What is the market cap of Biogen Pharmachem Industries Ltd (BIOGEN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biogen Pharmachem Industries Ltd (BIOGEN) is ₹84.84 Cr as of 18th July 2025.What is the 52 week high and low of Biogen Pharmachem Industries Ltd (BIOGEN) share?
The 52-week high of Biogen Pharmachem Industries Ltd (BIOGEN) is ₹1.57 and the 52-week low is ₹0.75.What is the PE and PB ratio of Biogen Pharmachem Industries Ltd (BIOGEN) stock?
The P/E (price-to-earnings) ratio of Biogen Pharmachem Industries Ltd (BIOGEN) is -292.57. The P/B (price-to-book) ratio is 1.50.Which sector does Biogen Pharmachem Industries Ltd (BIOGEN) belong to?
Biogen Pharmachem Industries Ltd (BIOGEN) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Biogen Pharmachem Industries Ltd (BIOGEN) shares?
You can directly buy Biogen Pharmachem Industries Ltd (BIOGEN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Biogen Pharmachem Industries Ltd
BIOGEN Share Price
0.931.06% (-0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BIOGEN Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BIOGEN Performance & Key Metrics
BIOGEN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -303.02 | 1.50 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.08 | 6.54 | 0.76% |
BIOGEN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BIOGEN Company Profile
Biogen Pharmachem Industries Ltd is currently inactive and seeking opportunities for operational engagement.
BIOCON
PE Ratio
52.29
52.29
1Y Return
16.19%
16.19%
Buy Reco %
73.33
73.33
ONESOURCE
PE Ratio
-1,276.08
-1,276.08
1Y Return
16.69%
16.69%
Buy Reco %
100.00
100.00
SAILIFE
PE Ratio
100.91
100.91
1Y Return
6.61%
6.61%
Buy Reco %
66.67
66.67
ACUTAAS
PE Ratio
62.34
62.34
1Y Return
82.57%
82.57%
Buy Reco %
100.00
100.00
PANACEABIO
PE Ratio
-320.19
-320.19
1Y Return
216.45%
216.45%
Buy Reco %
0.00
0.00
BIOGEN Forecast
BIOGEN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BIOGEN
BIOGEN
Income
Balance Sheet
Cash Flow
Annual Normal View
BIOGEN Income Statement
BIOGEN Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.16 | 0.95 | 0.00 | 1.62 | 2.48 | 0.91 | 2.38 | 0.84 | 0.84 | ||||||||||
Raw Materials | — | — | — | — | — | — | — | — | 1.13 | 1.12 | ||||||||||
| Power & Fuel Cost | — | — | — | — | — | — | — | — | ||||||||||||
| Employee Cost | 0.01 | 0.03 | 0.04 | 0.04 | 0.01 | 0.05 | 0.17 | 0.08 | ||||||||||||
| Selling & Administrative Expenses | — | — | — | — | — | — | — | — | ||||||||||||
| Operating & Other expenses | 0.12 | 6.69 | 0.92 | 0.08 | 3.21 | 2.43 | 0.28 | 0.37 | ||||||||||||
EBITDA | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.29 | -0.28 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.29 | -0.28 | ||||||||||
| Interest & Other Items | — | — | — | — | — | — | — | — | — | — | ||||||||||
| PBT | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.29 | -0.28 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.29 | -0.28 | ||||||||||
| EPS | -0.00 | -0.10 | -0.00 | -0.00 | -0.02 | 0.00 | 0.01 | 0.03 | 0.00 | -0.00 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
BIOGEN Company Updates
BIOGEN Stock Peers
BIOGEN Past Performance & Peer Comparison
BIOGEN Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation-basic on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Biogen Pharmachem Industries Ltd | -292.57 | 1.50 | — |
| Biocon Ltd | 52.29 | 2.10 | 0.28% |
| Onesource Specialty Pharma Ltd | -1,276.08 | 57.92 | — |
| Sai Life Sciences Ltd | 100.91 | 17.61 | — |
BIOGEN Stock Price Comparison
Compare BIOGEN with any stock or ETFCompare BIOGEN with any stock or ETF
BIOGEN
BIOGEN Holdings
BIOGEN Shareholdings
BIOGEN Promoter Holdings Trend
BIOGEN Promoter Holdings Trend
BIOGEN Institutional Holdings Trend
BIOGEN Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 27.70%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BIOGEN Shareholding Pattern
BIOGEN Shareholding Pattern
BIOGEN Shareholding History
BIOGEN Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing BIOGEN stock
smallcases containing BIOGEN stock
Looks like this stock is not in any smallcase yet.
BIOGEN Events
BIOGEN Events
BIOGEN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIOGEN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BIOGEN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIOGEN has not given any dividends in last 5 years
BIOGEN Dividends
BIOGEN Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBIOGEN Stock News & Opinions
BIOGEN Stock News & Opinions
Articles & Videos
Corporate
Biogen Pharmachem Industries to convene board meeting
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 23 July 2025.Powered by Capital Market - Live
1 day agoCapital Market - Live
Earnings
Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter
Net profit of Biogen Pharmachem Industries rose 59.46% to Rs 1.18 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net profit of Rs 1.93 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to convene board meeting
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Biogen Pharmachem Industries reports standalone net loss of Rs 0.31 crore in the December 2024 quarter
Net loss of Biogen Pharmachem Industries reported to Rs 0.31 crore in the quarter ended December 2024 as against net profit of Rs 0.06 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries announces board meeting date
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Biogen Pharmachem Industries reports standalone net loss of Rs 1.00 crore in the September 2024 quarter
Net loss of Biogen Pharmachem Industries reported to Rs 1.00 crore in the quarter ended September 2024 as against net profit of Rs 0.72 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to announce Quarterly Result
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to convene AGM
Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to hold AGM
Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries revises board meeting date
Biogen Pharmachem Industries has revised the meeting of the Board of Directors which was scheduled to be held on 9 August 2024. The meeting will now be held on 13 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant